![Abraham Meizler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Abraham Meizler
Vorstandsvorsitzender bei Advantech Bioscience Pharmaceutical Ltd.
Aktive Positionen von Abraham Meizler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Advantech Bioscience Pharmaceutical Ltd. | Vorstandsvorsitzender | 01.01.2010 | - |
Gründer | 01.01.2010 | - |
Karriereverlauf von Abraham Meizler
Ehemalige bekannte Positionen von Abraham Meizler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
KADIMASTEM LTD | Direktor/Vorstandsmitglied | 29.04.2014 | 17.12.2020 |
Meizler UCB Biopharma SA | Vorsitzender | 01.01.2012 | 01.12.2014 |
Meizler Biopharma SA
![]() Meizler Biopharma SA Pharmaceuticals: MajorHealth Technology Founded in 1990 with the objective of promoting the development of health in Brazil, Meizler Biopharma, 100% national company, specializes in and acquisition of new drugs and existing partnerships with the world's leading pharmaceutical biotech and device doctors. Aimed at public and private institutions, hospitals and clinics, Meizler Biopharma has full-service warehousing and distribution, dynamically structured to meet quickly, increasing government demand for high technology products and affordable prices | Gründer | 01.01.1990 | 01.01.2012 |
Präsident | 01.01.1990 | 01.01.2012 | |
Raziel Therapeutics RT Ltd.
![]() Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Direktor/Vorstandsmitglied | - | - |
Atme Comercio E Serviços Ltda.
![]() Atme Comercio E Serviços Ltda. Real Estate DevelopmentFinance Atme Comercio E Serviços Ltda. is a real estate services company based in Barueri, Brazil. provides real estate services. The Brazilian company was founded by Abraham Meizler. | Gründer | 01.01.2002 | - |
SCISPARC LTD. | Direktor/Vorstandsmitglied | 09.01.2014 | - |
Vorsitzender | 21.02.2013 | 09.01.2014 |
Ausbildung von Abraham Meizler
Getulio Vargas Foundation | Masters Business Admin |
Statistik
International
Israel | 5 |
Brasilien | 5 |
Operativ
Director/Board Member | 3 |
Founder | 3 |
Chairman | 2 |
Sektoral
Health Technology | 5 |
Finance | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SCISPARC LTD. | Health Technology |
KADIMASTEM LTD | Health Technology |
Private Unternehmen | 5 |
---|---|
Meizler UCB Biopharma SA | |
Meizler Biopharma SA
![]() Meizler Biopharma SA Pharmaceuticals: MajorHealth Technology Founded in 1990 with the objective of promoting the development of health in Brazil, Meizler Biopharma, 100% national company, specializes in and acquisition of new drugs and existing partnerships with the world's leading pharmaceutical biotech and device doctors. Aimed at public and private institutions, hospitals and clinics, Meizler Biopharma has full-service warehousing and distribution, dynamically structured to meet quickly, increasing government demand for high technology products and affordable prices | Health Technology |
Advantech Bioscience Pharmaceutical Ltd. | |
Atme Comercio E Serviços Ltda.
![]() Atme Comercio E Serviços Ltda. Real Estate DevelopmentFinance Atme Comercio E Serviços Ltda. is a real estate services company based in Barueri, Brazil. provides real estate services. The Brazilian company was founded by Abraham Meizler. | Finance |
Raziel Therapeutics RT Ltd.
![]() Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Health Technology |
- Börse
- Insiders
- Abraham Meizler
- Erfahrung